276: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech's slump
The Readout Loud
00:00
Controversy surrounding the approval of NERONE for ALS treatment
This chapter explores the panel vote on whether NERONE should be approved as a treatment for ALS, highlighting the overwhelming opposition due to concerns about clinical data, manufacturing consistency, and the FDA's regulatory flexibility in rare diseases. The frustration of the ALS community and the cost concerns of the therapy are also discussed.
Transcript
Play full episode
